Form 144 UNITED THERAPEUTICS Corp Filed by: EDGEMOND JAMES
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall, dragged by Alphabet and megacap tech; focus on Iran
- Oil falls almost 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
United Therapeutics Corp. (UTHR) PT Raised to $380 at Wells Fargo
August 20, 2024 4:53 AM EDTWells Fargo analyst Tiago Fauth raised the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $380.00 (from $350.00) while maintaining a Overweight rating.
The analyst comments "Thoughts on the stock. We previously modeled Yutrepia launching this year, as the FDA faced no legal hurdles in... More
